In July 2025, Genesis Healthcare filed for Chapter 11 bankruptcy protection, citing mounting legal costs arising from personal injury wrongful-death claims. Since then, attempts to sell the company's approximately 175 facilities have been complicated by accusations that almost every major bidder has “insider ties, past business relationships, or connections to controversial activities in the sector," revealing “an industry shaped by consolidation, distress, complexity, and a small circle of recurring players,” as detailed in reporting by Bloomberg Law.
The bankruptcy court rejected a proposed sale to a company associated with the co-founder of a private equity firm that was an investor in Genesis. Other creditors accused this investor of “slashing costs and quality of care” to drive profits, further claiming that he had used similar tactics in past bankruptcies of other nursing home operators and was only trying to acquire Genesis to shed its debt.
Another bidder was rejected after it was discovered that one of its minority investors was excluded from “participating in federal health programs following a settlement over allegations of misrepresentation to obtain an operating certificate.”
Even New Generation Health, or NewGen, whose winning bid is pending, had links to Genesis, having partnered on a venture involving 29 nursing homes. Furthermore, one of the investors providing capital to facilitate NewGen's purchase has been accused of financial fraud involving nursing homes by New Jersey and New York state officials.
These examples highlight how important it is for bankruptcy counsel to have a laser focus on diligencing potential bidders early in the process. Having professionals who are experts in unearthing information that a potential bidder is hoping will go undiscovered, such as past legal issues or links to relevant parties, is essential to ensuring bankruptcy counsel is armed with the facts needed to make an informed decision. Identifying these issues as soon as possible can help save time (and money), allowing counsel to reject unsuitable bidders and focus only on those that maximize relief to creditors and which will more likely pass muster with the court.
The Genesis sale underscores how ownership can be layered through related companies that separate operations from real estate and management, adding complexity for creditors and regulators. “We’ve consistently found how complex business structures and the opaque nature of the private equity industry obscured nursing home ownership, making it difficult for regulators to adequately track impacts and assess compliance,” said Matt Parr of advocacy group Private Equity Stakeholder Project.